Is Kopra Bio worth it?
Kopra Bio is listed on this directory under Biotech but has no user reviews yet, so there is no rating to judge it on. Check the product details below and the alternatives page before you commit.
This profile has not been claimed by the vendor, so the details here come from public sources rather than the company. Reviews are posted by users of this directory and are not edited by the vendor.
- Rating
- Not rated yet
- Reviews
- 0
- Category
- Biotech
- Profile
- Unclaimed
Is Kopra Bio legit or a scam?
Kopra Bio is a real company that sells through its own site at kopra.bio. This directory has not flagged it as a scam, but a listing cannot prove a vendor is safe for your data or your budget. Most software scams run through lookalike domains and fake resellers, so run these checks before you sign.
- 1.Buy only on kopra.bio and check the checkout page shows the same company name.
- 2.If it will touch customer or company data, ask for a SOC 2 Type II report or a completed security questionnaire.
- 3.Start on monthly billing or a paid pilot before you commit to an annual contract.
- 4.Pay by card or invoice. A vendor asking for a wire or crypto up front is a red flag.
- 5.Read the low-star reviews first, then compare Kopra Bio alternatives.
Kopra Bio pricing
Kopra Bio has not added plan prices to this profile, which usually means pricing is quoted after a demo. Check the pricing page on kopra.bio or ask for a quote, and get these four answers in writing:
- Price per seat, per usage unit, or flat, and the minimum you pay.
- Minimum contract term and whether it renews automatically.
- Setup, onboarding or integration fees.
- The cap on price increases at renewal.
Work at Kopra Bio? Buyers land here to check your pricing. Claim this profile to publish your plans, your own description and a dofollow link.
Kopra Bio Product Details
About
Kopra Bio makes genetically engineered viruses that teach your immune system to kill cancer using tech we developed at UCSF. We’re making the next Keytruda ($25B/yr cancer drug blockbuster) starting with the most aggressive form of brain cancer, glioblastoma. In the most challenging brain cancer model, we improve survival from 0% with the current FDA approved treatment to 90% with our treatment.
Detailed Information
Kopra Bio Reviews (0)
Leave a ReviewWrite a Review
You'll be asked to create an account when you submit your review.
No reviews yet. Be the first to review Kopra Bio.